Innovative Treatment Modality WellBrain offers a unique, non-opiate approach to managing chronic pain and anxiety through real-time cognitive assessments and measurable meditation techniques, which could appeal to healthcare providers seeking alternative treatment options.

Strategic Acquisitions The acquisition of Mevoked enhances WellBrain’s behavioral analytics capabilities and expands its focus to mental health conditions such as perinatal and postpartum disorders, presenting cross-selling opportunities in mental health care markets.

Target Market Potential Operating in the wellness and healthcare sector with a recent beta trial phase, WellBrain is positioned to tap into the growing demand for digital health solutions for pain and anxiety, particularly within clinics and hospitals seeking innovative non-pharmaceutical interventions.

Tech Stack & Scalability Utilizing a modern tech infrastructure with cloud services, web frameworks, and analytics tools, WellBrain is well-equipped to develop scalable, data-driven solutions, which can be a selling point for partners interested in robust health tech integrations.

Revenue Growth Potential With an estimated revenue between 1 million and 10 million dollars and backing by a team of renowned medical and neuroscientific experts, WellBrain presents opportunities for strategic partnerships and investment to accelerate product development and market expansion.